Tory Kaye

Most-cited papers

1. Prognostication and Biomarker Potential of C26:0 Lysophosphatidylcholine in Adrenoleukodystrophy.

   Charles J. Billington, Arpana Rayannavar, Rebecca Tryon, Tory Kaye +7 more

   2025JAMA pediatrics16 citations Open access

   Semantic Scholar

   Save

2. Disparities in late and lost: Pediatricians' role in following Pompe disease identified by newborn screening.

   Nishitha R. Pillai, N. Fabie, Tory Kaye, Sondra Rosendahl +5 more

   2023Molecular Genetics and Metabolism6 citations

   Semantic Scholar

   Save

3. Insights From Minnesota on Newborn Screening for Adrenoleukodystrophy: A 5‐Year Update

   Arpana Rayannavar, C. Billington, Rebecca Tryon, Tory Kaye +7 more

   2025American Journal of Medical Genetics. Part A5 citations Open access

   Semantic Scholar

   Save

4. When follow-up falls short: A case series on infants lost in newborn screening follow-up for mucopolysaccharidosis type I

   Tory Kaye, Karissa Tricas, Amy Dahle, Jenna Soukup +1 more

   2026Molecular Genetics and Metabolism0 citations

   Semantic Scholar

   Save

5. Newborn screening experience and outcome from a Minnesota Pompe disease consortium

   Nishitha R. Pillai, N. Fabie, Tory Kaye, Sondra Rosendahl +5 more

   2022Molecular Genetics and Metabolism0 citations

   Semantic Scholar

   Save